This inventor holds 3 USPTO granted patents. Top assignees: Emory University, Kyowa Hakko Bio Co., Ltd.. Active years: 2001-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2001-2011
Title: Thomas R Ziegler: Innovator in Medical Treatments
Introduction
Thomas R Ziegler is a notable inventor based in Lilburn, GA (US). He has made significant contributions to the field of medical treatments, holding a total of 3 patents. His work focuses on innovative compositions and methods aimed at improving health outcomes.
Latest Patents
Ziegler's latest patents include a composition and method for the treatment of stomatitis. This composition is effective in preventing or treating stomatitis and contains glutathione or a pharmaceutically acceptable salt thereof, along with orotic acid or its derivatives. Another significant patent involves the use of gut-trophic growth factors to improve oxidative status. This patent describes methods for minimizing oxidative damage during malnutrition, underfeeding, or fasting, particularly during refeeding after undernutrition. The administration of gut trophic growth factors (GTGF) is shown to enhance clinical conditions and outcomes for patients or animals.
Career Highlights
Throughout his career, Ziegler has worked with esteemed organizations such as Emory University and Kyowa Hakko Bio Co., Ltd. His experience in these institutions has allowed him to develop and refine his innovative ideas in medical treatments.
Collaborations
Ziegler has collaborated with notable individuals in his field, including Dean P Jones and Kenjiro Shimada. These collaborations have contributed to the advancement of his research and inventions.
Conclusion
Thomas R Ziegler's contributions to medical treatments through his patents demonstrate his commitment to innovation in healthcare. His work continues to impact the field positively, showcasing the importance of research and development in improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile